NCT05126316View on ClinicalTrials.gov

A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

July 12, 2022

Study Completion Date

August 25, 2022

Conditions
Allergic Rhinitis
Interventions
DRUG

Lu AG09222

Lu AG09222 will be administered per schedule specified in the arm description.

DRUG

Placebo

Placebo matching to Lu AG09222 will be administered per schedule specified in the arm description.

Trial Locations (2)

EC2Y 8EA

St Pancras Clinical Research, London

M23 9QZ

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT05126316 - A Trial to Learn More About Repeated Monthly Injections of Lu AG09222 in Participants With Allergies to Grass Pollen | Biotech Hunter | Biotech Hunter